Background The aim of this study was to systematically synthesise the global evidence on
the prevalence of persistent symptoms in a general post COVID-19 population. Methods A …

Long COVID is the patient-coined term for the disease entity whereby persistent symptoms
ensue in a significant proportion of those who have had COVID-19, whether asymptomatic …

First infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
associated with increased risk of acute and postacute death and sequelae in various organ …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with
a range of persistent symptoms impacting everyday functioning, known as post-COVID-19 …

The neurologic manifestations of acute COVID-19 are well characterized, but a
comprehensive evaluation of postacute neurologic sequelae at 1 year has not been …

The post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection—also referred to as Long COVID—have been described, but whether …

Background Patients often report various symptoms after recovery from acute COVID-19.
Previous studies on post-COVID-19 condition have not corrected for the prevalence and …

Post-acute infection syndromes may develop after acute viral disease. Infection with SARS-
CoV-2 can result in the development of a post-acute infection syndrome known as long …

COVID survivors frequently experience lingering neurological symptoms that resemble
cancer-therapy-related cognitive impairment, a syndrome for which white matter microglial …

Persistent neurological and neuropsychiatric symptoms affect a substantial fraction of
people after COVID-19 and represent a major component of the post-acute COVID-19 …